JAGSNPHARM
Invest with MTF
Invest Now
Invest in Jagsonpal Pharmaceuticals with 2.23X leverage
Jagsonpal Pharmaceuticals live price: ₹168.27. It opened at ₹172 vs previous close ₹173; intraday high/low: ₹173/₹162. The 50 & 200 DMA stand at ₹178.55/₹203.03.
Jagsonpal Pharmaceuticals Performance
- Low
- ₹162
- High
- ₹173
- 52 Week Low
- ₹155
- 52 Week High
- ₹302
- Open Price₹172
- Previous Close₹173
- Volume72,180
- 50 DMA₹178.55
- 100 DMA₹190.86
- 200 DMA₹203.03
Investment Returns
- Over 1 Month + 0.07%
- Over 3 Month -15.63%
- Over 6 Month -29.96%
- Over 1 Year -23.59%
Smart Investing Starts Here Start SIP with Jagsonpal Pharmaceuticals for Steady Growth!
Jagsonpal Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 27.5
- PEG Ratio
- -1.3
- Market Cap Cr
- 1,126
- P/B Ratio
- 4.3
- Average True Range
- 6.95
- EPS
- 6.37
- Dividend Yield
- 1.5
- MACD Signal
- -2.14
- RSI
- 43.36
- MFI
- 46.08
Jagsonpal Pharmaceuticals Financials
Jagsonpal Pharmaceuticals Technicals
EMA & SMA
Current Price
₹168.27
-5.07
(-2.92%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹171.87
- 50 Day
- ₹178.55
- 100 Day
- ₹190.86
- 200 Day
- ₹203.03
Resistance and Support
167.72
- R3 184.35
- R2 178.62
- R1 173.45
- S1 162.55
- S2 156.82
- S3 151.65
Jagsonpal Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Jagsonpal Pharmaceuticals F&O
About Jagsonpal Pharmaceuticals
- NSE Symbol
- JAGSNPHARM
- BSE Symbol
- 507789
- Managing Director
- Mr. Manish Gupta
- ISIN
- INE048B01035
Similar Stocks to Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals FAQs
Jagsonpal Pharmaceuticals share price is ₹168 As on 10 March, 2026 | 03:50
The Market Cap of Jagsonpal Pharmaceuticals is ₹1125.6 Cr As on 10 March, 2026 | 03:50
The P/E ratio of Jagsonpal Pharmaceuticals is 27.5 As on 10 March, 2026 | 03:50
The PB ratio of Jagsonpal Pharmaceuticals is 4.3 As on 10 March, 2026 | 03:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.